YU21391A - Triciklični-ciklični amini kao novi inhibitori holinesteraze - Google Patents

Triciklični-ciklični amini kao novi inhibitori holinesteraze

Info

Publication number
YU21391A
YU21391A YU21391A YU21391A YU21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A YU 21391 A YU21391 A YU 21391A
Authority
YU
Yugoslavia
Prior art keywords
cholinesterase inhibitors
tricyclic
hydrogen
ring
cyclic amines
Prior art date
Application number
YU21391A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Y.L. Chen
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU21391A publication Critical patent/YU21391A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU21391A 1990-02-08 1991-02-07 Triciklični-ciklični amini kao novi inhibitori holinesteraze YU21391A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (1)

Publication Number Publication Date
YU21391A true YU21391A (sh) 1994-01-20

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
YU21391A YU21391A (sh) 1990-02-08 1991-02-07 Triciklični-ciklični amini kao novi inhibitori holinesteraze

Country Status (21)

Country Link
EP (1) EP0441517A3 (enExample)
JP (1) JPH07119214B2 (enExample)
KR (1) KR950013562B1 (enExample)
CN (1) CN1054600A (enExample)
AU (1) AU631723B2 (enExample)
BR (1) BR9100519A (enExample)
CA (1) CA2035805C (enExample)
CS (1) CS29991A2 (enExample)
DE (1) DE9101348U1 (enExample)
EG (1) EG19644A (enExample)
FI (1) FI910592A7 (enExample)
HU (1) HUT70051A (enExample)
IE (1) IE910402A1 (enExample)
IL (1) IL97140A (enExample)
NO (1) NO177534C (enExample)
NZ (1) NZ237040A (enExample)
PL (2) PL167078B1 (enExample)
PT (1) PT96681A (enExample)
TW (1) TW197442B (enExample)
YU (1) YU21391A (enExample)
ZA (1) ZA91916B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (enExample) * 1991-10-03 1995-11-21 Pfizer
TW248556B (enExample) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
BR0315681A (pt) * 2002-10-30 2005-09-06 Merck Frosst Canada Inc Composto e seus sais e hidratos farmaceuticamente aceitáveis, composição farmacêutica, métodos para o tratamento de doenças mediadas pela prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, composto ou um seu sal ou solvato farmaceuticamente aceitável, sal ou hidrato do composto, e, uso de um composto ou de um seu sal ou solvato farmaceuticamente aceitável
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
MA50093B1 (fr) * 2017-09-07 2022-05-31 Eisai R&D Man Co Ltd Composé pentacyclique
EP3936190A4 (en) 2019-03-05 2022-11-16 Eisai R&D Management Co., Ltd. PENTACYCLIC HETEROCYCLIC COMPOUND
CA3129764A1 (en) * 2019-03-05 2020-09-10 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
CS29991A2 (en) 1991-09-15
NO910473L (no) 1991-08-09
IL97140A (en) 1995-07-31
HU910406D0 (en) 1991-08-28
EP0441517A3 (en) 1992-08-19
AU7087991A (en) 1991-08-29
TW197442B (enExample) 1993-01-01
JPH07119214B2 (ja) 1995-12-20
CN1054600A (zh) 1991-09-18
KR910015580A (ko) 1991-09-30
NO177534B (no) 1995-06-26
NO177534C (no) 1995-10-04
IL97140A0 (en) 1992-05-25
HUT70051A (en) 1995-09-28
KR950013562B1 (ko) 1995-11-09
ZA91916B (en) 1992-09-30
PL167078B1 (pl) 1995-07-31
PT96681A (pt) 1991-10-31
PL288977A1 (en) 1992-01-13
FI910592L (fi) 1991-08-09
NZ237040A (en) 1993-10-26
EP0441517A2 (en) 1991-08-14
FI910592A0 (fi) 1991-02-07
FI910592A7 (fi) 1991-08-09
BR9100519A (pt) 1991-10-29
CA2035805C (en) 1995-06-27
EG19644A (en) 1995-08-30
DE9101348U1 (de) 1991-06-06
PL166757B1 (pl) 1995-06-30
JPH04234845A (ja) 1992-08-24
NO910473D0 (no) 1991-02-07
AU631723B2 (en) 1992-12-03
IE910402A1 (en) 1991-08-14

Similar Documents

Publication Publication Date Title
MY108967A (en) Triazolopyridazine compounds, their production and use
SE8307133D0 (sv) Carboxamido-derivatives of 5h-1,3,4-thiadiazolo(3,2-a)pyrimidines and process for their preparation
EP0487502A3 (en) Pharmaceutically active aryl-substituted amine derivatives
NO810479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
MA20861A1 (fr) nouveaux derives de dihydrobenzofuranne et de chromane carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques.
FI914015A0 (fi) Menetelmä farmaseuttisesti aktiivisten 7-substituoitu-2-amino-3,5-dihydro-4H-pyrrolo/3,2-d/pyrimidin-4-onien valmistamiseksi
ATE34575T1 (de) Neue theophyllin-derivate und verfahren zu ihrer herstellung.
ATE185143T1 (de) Glatten-muskelzellen-proliferation-inhibitoren
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
FR2373546A1 (fr) Derives thio-oxime de cephalosporines et de penicillines, utiles comme inhibiteurs de b-lactamases
JPS5321188A (en) Cephalosporin analogs
ES8105309A1 (es) Un procedimiento para la preparacion de nuevos derivados de cromano.
PT76335B (de) Neue basisch substituierte 4-phenyl-4,5,6,7-tetrahydro-thieno-<2,3-c>pyridine verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
DE3275995D1 (de) 4-aroylimidazolidin-2-ones
ES8605256A1 (es) Un procedimiento para la preparacion de derivados de 2-feniletilamina.
NZ221054A (en) Imidazo (2,1-a) isoquinoline derivatives and pharmaceutical compositions
YU68292A (sh) 2-(2-supstituisani pirolidiniltio) karbapenem derivati
IL67564A0 (en) (1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
YU55495A (sh) Upotreba benzotiofena za dobijanje leka
DE3160719D1 (en) Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them
FI821944A0 (fi) Tricykliska foereningar
NO885811L (no) Fremgangsmaate for fremstilling av 2-amino-tetrahydroisokinolinderivater.